SCHEMBL1895673

SCHEMBL1895673

CCCNC=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899064 0.81
SCHEMBL4201267 0.72 ADH1B (0.56)
SCHEMBL20080360 0.72 ADH1B (0.56)
SCHEMBL4201273 0.72 ADH1B (0.56)
SCHEMBL1892103 0.72
SCHEMBL12895646 0.71
SCHEMBL15829904 0.69
SCHEMBL15744 0.69
SCHEMBL21280277 0.68
SCHEMBL22755592 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148030-A1 KETO ACID BIOPOLYMERS AND POLYOL KETO ESTERS AND USES THEREOF ATOSSA THERAPEUTICS, INC. (US) 2024-07-11 WO disclosed
WO-2024018403-A1 SUBSTITUTED IMIDAZOAMIDE COMPOUNDS, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2024-01-25 WO disclosed
WO-2023066292-A1 TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 上海济煜医药科技有限公司 2023-04-27 WO disclosed
EP-2668180-B1 BCL-2/BCL-XL INHIBITORS FOR USE IN THE TREATMENT OF CANCER UNIV MICHIGAN REGENTS (US) 2018-08-01 EP disclosed
US-10004702-B2 Linear guanidine derivatives, methods of preparation and uses thereof LEAD DISCOVERY SIENA S.R.L. (IT) 2018-06-26 US disclosed
WO-2017197488-A1 LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME CYCLENIUM PHARMA INC. (CA) 2017-11-23 WO disclosed
US-20170304235-A1 LINEAR GUANIDINE DERIVATIVES, METHODS OF PREPARATION AND USES THEREOF LEAD DISCOVERY SIENA S.R.L. (IT) 2017-10-26 US disclosed
US-20170096692-A1 CELL-FREE PREPARATION OF CARBAPENEMS GREENLIGHT BIOSCIENCES, INC. (US) 2017-04-06 US disclosed
US-9469861-B2 Cell-free preparation of carbapenems GREENLIGHT BIOSCIENCES, INC. (US) 2016-10-18 US disclosed
WO-2016105448-A1 IMIDAZOLINE RECEPTOR TYPE 1 LIGANDS FOR USE AS THERAPEUTICS RIDEOUT DARRYL (US) 2016-06-30 WO disclosed
WO-2006076243-A1 PROCESSES FOR PREPARING 4-(PHENOXY-5-METHYL-PYRIMIDIN-4-YLOXY)PIPERIDINE-1-CARBOXYLIC ACID DERIVATIVES AND RELATED COMPOUNDS ARENA PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed
WO-2006076455-A2 PROCESSES FOR PREPARING PYRAZOLO[3,4-D]PYRIMIDINE ETHERS ARENA PHARMACEUTICALS, INC. (US) 2006-07-20 WO disclosed
US-20060154940-A1 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers ARENA PHARMACEUTICALS, INC. 2006-07-13 US disclosed
US-20060155129-A1 Processes for preparing aromatic ethers ARENA PHARMACEUTICALS, INC. 2006-07-13 US disclosed
WO-2006069242-A2 FUSED PYRAZOLE DERIVATIVES AND USES THEREOF IN METHODS OF TREATMENT OF METABOLIC-RELATED?DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2006-06-29 WO disclosed
WO-2005113553-A2 AZINYL IMIDAZOAZINE AND AZINYL CARBOXAMIDE BAYER CROPSCIENCE AG (DE) 2005-12-01 WO disclosed
WO-2005007647-A9 TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2005-04-07 WO disclosed
US-20050070562-A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. 2005-03-31 US disclosed
US-5264448-A Thioamides, oxazole ring, insecticides, miticides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-11-23 US disclosed
EP-0394043-A1 An amide compound and its production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-10-24 EP disclosed